首页> 外文期刊>Oncology letters >Reconstruction of mandibular defects with autogenous bone and decellularized bovine bone grafts with freeze-dried bone marrow stem cell paracrine factors
【24h】

Reconstruction of mandibular defects with autogenous bone and decellularized bovine bone grafts with freeze-dried bone marrow stem cell paracrine factors

机译:用冻干骨髓干细胞邻静脉因子重建骨髓缺陷颌骨缺陷

获取原文
获取原文并翻译 | 示例
           

摘要

The gold standard following segmental mandibulectomy is vascularized autologous bone graft in the form of the fibula flap. However, in bone reconstruction the use of autogenous bone does not always guarantee a successful outcome. The aim of the present investigation was to develop a novel biologically active bone (BAB) graft, and to use it for the reconstruction of large size defects of the mandible bone following tumor resection. In the first part of the present study, biologically active bone graft was developed by using human freeze-dried bone marrow stem cells (BMSCs) paracrine factors and three-dimensional bone scaffold derived from cancellous bovine bone following decellularization. In the second part of the research, one male and three female patients with primary tumors of the mandible underwent hemimandibulectomy. The mandibular bone defects following tumor resection were reconstructed with autogenous rib grafts in three patients and BAB graft was used in one patient. The graft-host interfaces were covered with decellularized human amnion/chorion membrane graft. All patients were followed-up every five months following the reconstruction of the mandible, with no complications observed. Preliminary clinical investigations demonstrated that a BAB graft containing freeze-dried BMSC paracrine factors may be used for the reconstruction of large mandibular bone defects following tumor resection.
机译:在节段性悬臂切除术后的黄金标准是血管瓣形式的血管化自体骨移植物。然而,在骨重建中,使用自体骨并不总是保证成功的结果。本研究的目的是开发一种新型的生物活性骨(BAB)移植物,并使用它来重建肿瘤切除后颌骨骨的大尺寸缺陷。在本研究的第一部分中,通过使用人冷冻干燥的骨髓干细胞(BMSCs)旁静脉因子和三维骨支架衍生自脱细胞化后衍生自质牛骨的三维骨支架来开发生物活性骨移植。在研究的第二部分,一名雄性和三位女性患者颌骨原发性肿瘤的颌骨肿瘤。在三名患者中,用自身源肋移植物重建肿瘤切除后的下颌骨缺陷,并在一名患者中使用Bab移植物。将移植物 - 宿主界面覆盖有脱细胞的人羊膜/绒毛膜膜移植物。在重建下颌骨后,所有患者均在每五个月后进行一次,没有观察到并发症。初步临床研究表明,含有冷冻干燥的BMSC旁静脉因子的Bab移植物可用于在肿瘤切除后重建大下颌骨缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号